Oxidative stress in diabetes: Implications for vascular and other complications

International Journal of Molecular Sciences

Volumn 14, Issue 11, 2013, Pages 21525-21550

  Pitocco, Dario ^a   Tesauro, Manfredi ^b   Alessandro, Rizzi ^a   Ghirlanda, Giovanni ^a   Cardillo, Carmine ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

cell dysfunction; Diabetes mellitus; Insulin resistance; Oxidative stress; Reactive oxidative species; Vascular complications

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; INSULIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; THIOCTIC ACID;

ATHEROGENESIS; ATHEROSCLEROSIS; CAUSE OF DEATH; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIABETOGENESIS; ENZYME ACTIVITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; LIPID PEROXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; INSULIN RESISTANCE; OBESITY; OXIDATIVE STRESS;

EID: 84886816599     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141121525     Document Type: Review

References (170)

1. D'Autreaux, B. Toledano, M.B. ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 2007, 8, 813-824.
2. Ibrahim, W. Tatumi, V. Yeh, C.C. Hong, C.B. Chow, C.K. Effects of dietary carnosine and vitamin E on antioxidant and oxidative status of rats. Int. J. Vitam. Nutr. Res. 2008, 78, 230-237.
3. Valdivia, P.A. Zenteno-Savin, T. Gardner, S.C. Aguirre, A.A. Basic oxidative stress metabolites in eastern Pacific green turtles (Chelonia mydas agassizii). Comp. Biochem. Physiol. Toxicol. Pharmacol. 2007, 146, 111-117.
4. Camera, E. Picardo, M. Analytical methods to investigate glutathione and related compounds in biological and pathological processes. J. Chromatogr. Anal. Technol. Biomed. Life Sci. 2002, 781, 181-206.
5. Tarpey, M.M. Wink, D.A. Grisham, M.B. Methods for detection of reactive metabolites of oxygen and nitrogen: In vitro and in vivo considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286, R431-R444.
6. Palmieri, B. Sblendorio, V. Oxidative stress tests: Overview on reliability and use. Eur. Rev. Med. Pharmacol. Sci. 2007, 11, 309-342.
7. Jones, D.P. Redox potential of GSH/GSSG couple: Assay and biological significance. Methods Enzymol. 2002, 348, 93-112.
8. Dambrova, M. Baumane, L. Kalvinsh, I. Wikberg, J.E. Improved method for EPR detection of DEPMPO superoxide radicals by liquid nitrogen freezing. Biochem. Biophys. Res. Commun. 2000, 275, 895-898.
9. Laurindo, F.R. Pedro, M.D. Barbeiro, H.V. Pileggi, F. Carvalho, M.H. Augusto, O. da Luz, P.L. Vascular free radical release ex vivo and in vivo evidence for a flowdependent endothelial mechanism. Circ. Res. 1994, 74, 700-709.
10. Pryor, W.A. Stanley, J.P. Blair, E. Autoxidation of polyunsaturated fatty acids: II. A suggested mechanism for the formation of TBA-reactive materials from prostaglandin-like endoperoxides. Lipids 1976, 11, 370-379.
11. Wallin, B. Rosengren, B. Shertzer, H.G. Camejo, G. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiterplate: Its use for evaluation of antioxidants. Anal. Biochem. 1993, 208, 10-15.
12. Roberts, L.J. Morrow, J.D. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic. Biol. Med. 2000, 28, 505-513.
13. Aberti, A. Bolognini, L. Caratelli, M. Della Bona, M.A. Mavviantelli, D. Assessing Oxidative Stress with the DRoms Test. Some Mechanistic Consideration. In Proceedings of the SFRR Summer Meeting; Europe Summer Meeting: Abano Terme, Padova, Italy, 26-28 June 1997; pp. 82-83.
14. Ellis, G. Adatia, I. Yazdanpanah, M. Makela, S.K. Nitrite and nitrate analyses: A clinical biochemistry perspective. Clin. Biochem. 1998, 31, 195-220.
15. Tsikas, D. Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radic. Res. 2005, 39, 797-815.
16. Wennmalm, A. Benthin, G. Edlund, A. Jungersten, L. Kieler-Jensen, N. Lundin, S. Westfelt, U.N. Petersson, A.S. Waagstein, F. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ. Res. 1993, 73, 1121-1127.
17. Leone, A.M. Francis, P.L. Rhodes, P. Moncada, S. A rapid and simple method for the measurement of nitrite and nitrate in plasma by high performance capillary electrophoresis. Biochem. Biophys. Res. Commun. 1994, 200, 951-957.
18. Everett, S.A. Dennis, M.F. Tozer, G.M. Prise, V.E. Wardman, P. Stratford, M.R. Nitric oxide in biological fluids: Analysis of nitrite and nitrate by high-performance ion chromatography. J. Chromatogr. 1995, 706, 437-442.
19. Tsikas, D. Gutzki, F.M. Rossa, S. Bauer, H. Neumann, C. Dockendorff, K. Sandmann, J. Frolich, J.C. Measurement of nitrite and nitrate in biological fluids by gas chromatography-mass spectrometry and by the Griess assay: Problems with the Griess assay-Solutions by gas chromatography-mass spectrometry. Anal. Biochem. 1997, 244, 208-220.
20. Becker, A.J. Uckert, S. Tsikas, D. Noack, H. Stief, C.G. Frolich, J.C. Wolf, G. Jonas, U. Determination of nitric oxide metabolites by means of the Griess assay and gas chromatography-mass spectrometry in the cavernous and systemic blood of healthy males and patients with erectile dysfunction during different functional conditions of the penis. Urol. Res. 2000, 28, 364-369.
21. Romitelli, F. Santini, S.A. Chierici, E. Pitocco, D. Tavazzi, B. Amorini, A.M. Lazzarino, G. di Stasio, E. Comparison of nitrite/nitrate concentration in human plasma and serum samples measured by the enzymatic batch Griess assay, ion-pairing HPLC and ion-trap GC-MS: The importance of a correct removal of proteins in the Griess assay. J. Chromatogr. Analyt. Technol. Biomed. Life Sci. 2007, 851, 257-267.
22. Schwedhelm, E. Quantification of ADMA: Analytical approaches. Vasc. Med. 2005, 10, S89-S95.
23. Siroka, R. Trefil, L. Rajdl, D. Racek, J. Cibulka, R. Asymmetric dimethylarginine-Comparison of HPLC and ELISA methods. Chromatogr. Analyt. Technol. Biomed. Life Sci. 2007, 850, 586-587.
24. Borek, C. Dietary antioxidants and human cancer. Integr. Cancer Ther. 2004, 3, 333-341.
25. Said, T.M. Kattal, N. Sharma, R.K. Sikka, S.C. Thomas, A.J., Jr. Mascha, E. Agarwal, A. Enhanced chemiluminescence assay vs. colorimetric assay for measurement of the total antioxidant capacity of human seminal plasma. J. Androl. 2003, 24, 676-680.
26. Kanda, M. Ihara, Y. Murata, H. Urata, Y. Kono, T. Yodoi, J. Seto, S. Yano, K. Kondo, T. Glutaredoxin modulates platelet-derived growth factor-dependent cell signaling by regulating the redox status of low molecular weight protein-tyrosine phosphatase. J. Biol. Chem. 2006, 281, 28518-28528.
27. Sundaresan, M. Yu, Z.X. Ferrans, V.J. Irani, K. Finkel, T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995, 270, 296-299.
28. Bedrad, K. Krause, K.H. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol. Rev. 2007, 87, 245-313.
29. Pacher, P. Beckman, J.S. Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87, 315-424.
30. Zhang, D.X. Gutterman, D.D. Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2007, 292, H2023-H2031.
31. Zangar, R.C. Davydov, D.R. Verma, S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol. Appl. Pharmacol. 2004, 199, 316-331.
32. Evans, J.L. Goldfine, I.D. Maddux, B.A. Grodsky, G.M. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr. Rev. 2002, 23, 599-622.
33. Gutterman, D.D. Miura, H. Liu, Y. Redox modulation of vascular tone: Focus of potassium channel mechanisms of dilation. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 671-678.
34. Chiarugi, P. Pani, G. Giannoni, E. Taddei, L. Colavitti, R. Raugei, G. Symons, M. Borrello, S. Galeotti, T. Ramponi, G. Reactive oxygen species as essential mediators of cell adhesion: The oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J. Cell Biol. 2003, 161, 933-944.
35. Grisham, M.B. Reactive oxygen species in immune responses. Free Radic. Biol. Med. 2004, 36, 1479-1480.
36. Droge, W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82, 47-95.
37. Lee, H.C. Wie, Y.H. Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Exp. Biol. Med. 2007, 232, 592-606.
38. Storz, P. Reactive oxygen species in tumor progression. Front. Biosci. 2005, 10, 1881-1896.
39. Madamanchi, N.R. Vendrov, A. Runge, M.S. Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 29-38.
40. Knight, J.A. Reactive oxygen species and the neurodegenerative disorders. Ann. Clin. Lab. Sci. 1997, 27, 11-25.
41. Bashan, N. Kovsan, J. Kachko, I. Ovadia, H. Rudich, A. Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol. Rev. 2009, 89, 27-71.
42. Du, X. Stocklauser-Farber, K. Rosen, P. Generation of reactive oxygen intermediates, activation of NF-κB and induction of apoptosis in human endothelial cells by glucose: Role of nitric oxide synthase? Free Radic. Biol. Med. 1999, 27, 752-763.
43. Gupta, S. Chough, E. Daley, J. Oates, P. Tornheim, K. Ruderman, N.B. Keaney, J.F., Jr. Hyperglycemia increases endothelial superoxide that impairs smooth muscle cell Na+-K+-ATPase activity. Am. J. Physiol. Cell Physiol. 2002, 282, C560-C566.
44. Mullarkey, C.J. Edelstein, D. Brownee, M. Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun. 1990, 173, 932-939.
45. Nishikawa, T. Edelstein, D. Du, X.L. Yamagishi, S. Matsumura, T. Kaneda, Y. Yorek, M.A. Beebe, D. Oates, P.J. Hammes, H.P. et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404, 787-790.
46. Du, X.L. Edelstein, D. Rossetti, L. Fantus, I.G. Goldberg, H. Ziyadeh, F. Wu, J. Brownlee, M. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl. Acad. Sci. USA 2000, 97, 1222-1226.
47. Martens, G.A. Cai, Y. Hinke, S. Stange, G. van de Casteele, M. Pipeleers, D. Glucose suppresses superoxide generation in metabolically responsive pancreatic β-cells. J. Biol. Chem. 2005, 280, 20389-20396.
48. Herlein, J.A. Fink, B.D. O'Malley, Y. Sivitz, W.I. Superoxide and respiratory coupling in mitochondria of insulin-deficient diabetic rats. Endocrinology 2009, 150, 46-55.
49. Hou, N. Torii, S. Saito, N. Hosaka, M. Takeuchi, T. Reactive oxygen species-mediated pancreatic β-cell death is regulated by interactions between stressactivated protein kinases, p38 and c-Jun N-terminal kinase and mitogen-activated protein kinase phosphatases. Endocrinology 2008, 149, 1654-1665.
50. Poitout, V. Robertson, R.P. Glucolipotoxicity: Fuel excess and β-cell dysfunction. Endocr. Rev. 2008, 29, 351-366.
51. El-Assaad, W. Buteau, J. Peyot, M.L. Nolan, C. Roduit, R. Hardy, S. Joly, E. Dbaibo, G. Rosenberg, L. Prentki, M. Saturated fatty acids synergize with elevated glucose to cause pancreatic β-cell death. Endocrinology 2003, 144, 4154-4163.
52. Harmon, J.S. Gleason, C.E. Tanaka, Y. Poitout, V. Robertson, R.P. Antecedent hyperglycemia, not hyperllipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats. Diabetes 2001, 50, 2481-2486.
53. Robertson, R.P. Zhang, H.J. Pyzdrowski, K.L. Walseth, T.F. Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J. Clin. Investig. 1992, 90, 320-325.
54. Kaneto, H. Fujii, J. Myint, T. Miyazawa, N. Islam, K.N. Kawasaki, Y. Suzuki, K. Makamura, M. Tatsumi, H. Yamasaki, Y. et al. Reducing sugars trigger oxidative modification and apoptosis in pancreatic β-cells by provoking oxidative stress through the glycation reaction. Biochem. J. 1996, 320, 855-863.
55. Tajiri, Y. Moller, C. Grill, V. Long term effects of aminoguanidine on insulin release and biosynthesis: Evidence that the formation of advanced glycosylation end products inhibits β-cell function. Endocrinology 1997, 138, 273-280.
56. Tanaka, Y. Gleason, C.E. Tran, P.O. Harmon, J.S. Robertson, R.P. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc. Natl. Acad. Sci. USA 1999, 96, 10857-10862.
57. Sakai, K. Matsumoto, K. Nishikawa, T. Suefuji, M. Nakamaru, K. Hirashima, Y. Kawashima, J. Shirotani, T. Ichinose, K. Brownlee, M. et al. Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β-cells. Biochem. Biophys. Res. Commun. 2003, 300, 216-222.
58. Krauss, S. Zhang, C.Y. Scorrano, L. Dalgaard, L.T. St-Pierre, J. Grey, S.T. Lowell, B.B. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β-cell dysfunction. J. Clin. Investig. 2003, 112, 1831-1842.
59. Pi, J. Bai, Y. Zhang, Q. Wong, V. Floering, L.M. Daniel, K. Reece, J.M. Deeney, J.T. Andersen, M.E. Corkey, B.E. et al. Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes 2007, 56, 1783-1791.
60. LeLoup, C. Tourrel-Cuzin, C. Magnan, C. Karaca, M. Castel, J. Carneiro, L. Colombani, A.L. Ktorza, A. Casteilla, L. Pénicaud, L. Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion. Diabetes 2009, 58, 673-681.
61. Li, N. Brun, T. Chop, M. Cunha, D.A. Eizirik, D.L. Maechler, P. Transient exposure of β-cells to oxidative stress interrupts the transduction of signals normally coupling glucose metabolism to insulin secretion. J. Biol. Chem. 2009, 284, 23602-23612.
62. Fridlyand, L.E. Philipson, L.H. Does the glucose-dependent insulin secretion mechanism itself cause oxidative stress in pancreatic β-cells? Diabetes 2004, 53, 1942-1948.
63. Czech, M.P. Lawrence, J.C., Jr. Lynn, W.S. Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin. Proc. Natl. Acad. Sci. USA 1974, 71, 4173-4177.
64. Higaki, Y. Mikami, T. Fujii, N. Hirshman, M.F. Koyama, K. Seino, T. Tanaka, K. Goodyear, L.J. Oxidative stress stimulates skeletal muscle glucose uptake through a phosphatidylinositol-3-kinase-dependent pathway. Am. J. Physiol. Endocrinol. Metab. 2008, 294, E889-E897.
65. May, J.M. de Haen, C. The insulin-like effect of hydrogen peroxide on pathways of lipid synthesis in rat adipocytes. J. Biol. Chem. 1979, 254, 9017-9021.
66. Powell, D.J. Hajduch, E. Kular, G. Hundal, H.S. Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCζ-dependent mechanism. Mol. Cell Biol. 2003, 23, 7794-7808.
67. Imoto, K. Kukidome, D. Nishikawa, T. Matsuhisa, T. Sonoda, K. Fujisawa, K. Yano, M. Motoshima, H. Taguchi, T. Tsuruzoe, K. et al. Impact of mitochondrial reactive oxygen species and apoptosis signal-regulating kinase 1 on insulin signaling. Diabetes 2006, 55, 1197-1204.
68. Hotamisligil, G.S. Budavari, A. Murray, D. Spiegelman, B.M. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-α. J. Clin. Investig. 1994, 94, 1543-1549.
69. Uysal, K.T. Wiesbrock, S.M. Marino, M.W. Hotamisligil, G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 1997, 389, 610-614.
70. Zhang, L. Wheatley, C.M. Richards, S.M. Barrett, E.J. Clark, M.G. Rattigan, S. TNF-α acutely inhibits vascular effects of physiological but not high insulin or contraction. Am. J. Physiol. Endocrinol. Metab. 2003, 285, E654-E660.
71. Yoshizumi, M. Perrella, M.A. Burnett, J.C. Lee, M.E. Tumor necrosis factor downregulates endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 1993, 73, 205-209.
72. Mohamed, F. Monge, J.C. Gordon, A. Cernacek, P. Blais, D. Stewart, D.J. Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-α. Arterioscler. Thromb. Vasc. Biol. 1995, 15, 52-57.
73. De Keulenaer, G.W. Alexander, R.W. Ushio-Fukai, M. Ishizaka, N. Griendling, K.K. Tumour necrosis factor α activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem. J. 1998, 329, 653-657.
74. Hotamisligil, G.S. Peraldi, P. Budavari, A. Ellis, R. White, M.F. Spiegelman, B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 1996, 271, 665-668.
75. Rask-Madsen, C. Dominguez, H. Ihlemann, N. Hermann, T. Kober, L. Torp-Pedersen, C. Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation 2003, 108, 1815-1821.
76. Ziccardi, P. Nappo, F. Giugliano, G. Esposito, K. Marfella, R. Cioffi, M. D'Andrea, F. Molinari, A.M. Giugliano, D. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002, 105, 804-809.
77. Tesauro, M. Schinzari, F. Rovella, V. Melina, D. Mores, N. Barini, A. Mettimano, M. Lauro, D. Iantorno, M. Quon, M.J. et al. Tumor necrosis factor-α antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome. Diabetes Care 2008, 31, 1439-1441.
78. Tesauro, M. Canale, M.P. Rodia, G. di Daniele, N. Lauro, D. Scuteri, A. Cardillo, C. Metabolic syndrome, chronic kidney, and cardiovascular diseases: Role of adipokines. Cardiol. Res. Pract. 2011, 2011, 653182.
79. Moriwaki, Y. Inokuchi, T. Yamamoto, A. Ka, T. Tsutsumi, Z. Takahashi, S. Yamamoto, T. Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats. Acta Diabetol. 2007, 44, 215-218.
80. Westermann, D. van Linthout, S. Dhayat, S. Dhayat, N. Schmidt, A. Noutsias, M. Song, X.Y. Spillmann, F. Riad, A. Schultheiss, H.P. et al. Tumor necrosis factor-α antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res. Cardiol. 2007, 102, 500-507.
81. Schaffer, S.W. Jong, C.J. Mozaffari, M. Role of oxidative stress in diabetes-mediated vascular dysfunction: Unifying hypothesis of diabetes revisited. Vascul. Pharmacol. 2012, 57, 139-149.
82. Campia, U. Tesauro, M. Cardillo, C. Human obesity and endothelium-dependent responsiveness. Br. J. Pharmacol. 2012, 165, 561-573.
83. Tesauro, M. Cardillo, C. Obesity, blood vessels and metabolic syndrome. Acta Physiol. (Oxf.) 2011, 203, 279-286.
84. Stadler, K. Oxidative stress in diabetes. Adv. Exp. Med. Biol. 2012, 771, 272-287.
85. Houstis, N. Rosen, E.D. Lander, E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440, 944-948.
86. Furukawa, S. Fujita, T. Shimabukuro, M. Iwaki, M. Yamada, Y. Nakajima, Y. Nakayama, O. Makishima, M. Matsuda, M. Shimomura, I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Investig. 2004, 114, 1752-1761.
87. Svegliati-Baroni, G. Candelaresi, C. Saccomanno, S. Ferretti, G. Bachetti, T. Marzioni, M. de Minicis, S. Nobili, L. Salzano, R. Omenetti, A. et al. A model of insulin resistance and nonalcoholic steatohepatitis in rats: Role of peroxisome proliferator-activated receptor-α and n-3 polyunsaturated fatty acid treatment on liver injury. Am. J. Pathol. 2006, 169, 846-860.
88. Davi, G. Chiarelli, F. Santilli, F. Pomilio, M. Vigneri, S. Falco, A. Basili, S. Ciabattoni, G. Patrono, C. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: Role of interleukin-6 and disease duration. Circulation 2003, 107, 3199-3203.
89. Monnier, L. Mas, E. Ginet, C. Michel, F. Villon, L. Cristol, J.P. Colette, C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006, 295, 1681-1687.
90. Davi, G. Ciabattoni, G. Consoli, A. Mezzetti, A. Falco, A. Santarone, S. Pennese, E. Vitacolonna, E. Bucciarelli, T. Costantini, F. et al. In vivo formation of 8-isoprostaglandin F2α and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation. Circulation 1999, 99, 224-229.
91. Savu, O. Ionescu-Tirgoviste, C. Atanasiu, V. Gaman, L. Papacocea, R. Stoian, I. Increase in total antioxidant capacity of plasma despite high levels of oxidative stress in uncomplicated type 2 diabetes mellitus. J. Int. Med. Res. 2012, 40, 709-716.
92. Marra, G. Cotroneo, P. Pitocco, D. Manto, A. di Leo, M.A. Ruotolo, V. Caputo, S. Giardina, B. Ghirlanda, G. Santini, S.A. Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: A case for gender difference. Diabetes Care 2002, 25, 370-375.
93. Pitocco, D. di Stasio, E. Romitelli, F. Zaccardi, F. Tavazzi, B. Manto, A. Caputo, S. Musella, T. Zuppi, C. Santini, S.A. et al. Hypouricemia linked to an overproduction of nitric oxide is an early marker of oxidative stress in female subjects with type 1 diabetes. Diabetes Metab. Res. Rev. 2008, 24, 318-323.
94. Weber, C. Zernecke, A. Libby, P. The multifaceted contributions of leukocyte subsets to atherosclerosis: Lessons from mouse models. Nat. Rev. Immunol. 2008, 8, 802-815.
95. MacNaul, K.L. Hutchinson, N.I. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem. Biophys. Res. Commun. 1993, 196, 1330-1334.
96. Ceriello, A. Esposito, K. Piconi, L. Ihnat, M.A. Thorpe, J.E. Testa, R. Boemi, M. Giugliano, D. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008, 57, 1349-1354.
97. Ceriello, A. Mercuri, F. Quagliaro, L. Assaloni, R. Motz, E. Tonutti, L. Taboga, C. Detection of nitrotyrosine in the diabetic plasma: Evidence of oxidative stress. Diabetologia 2001, 44, 834-838.
98. Tannous, M. Rabini, R.A. Vignini, A. Moretti, N. Fumelli, P. Zielinski, B. Mazzanti, L. Mutus, B. Evidence for iNOS-dependent peroxynitrite production in diabetic platelets. Diabetologia 1999, 42, 539-544.
99. Frustaci, A. Kajstura, J. Chimenti, C. Jakoniuk, I. Leri, A. Maseri, A. Nadal-Ginard, B. Anversa, P. Myocardial cell death in human diabetes. Circ. Res. 2000, 87, 1123-1132.
100. Pacher, P. Obrosova, I.G. Mabley, J.G. Szabó, C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr. Med. Chem. 2005, 12, 267-275.
101. Pacher, P. Szabó, C. Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr. Opin. Pharmacol. 2006, 6, 136-141.
102. Pacher, P. Schulz, R. Liaudet, L. Szabo, C. Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol. Sci. 2005, 26, 302-310.
103. Virág, L. Szabó, C. The therapeutic potential of PARP inhibition. Pharmacol. Rev. 2002, 54, 375-429.
104. Szabó, C. Zanchi, A. Komjati, K. Pacher, P. Krolewski, A.S. Quist, W.C. LoGerfo, F.W. Horton, E.S. Veves, A. Poly(ADP-ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 2002, 106, 2680-2686.
105. Garcia Soriano, F. Virág, L. Jagtap, P. Szabó, E. Mabley, J.G. Liaudet, L. Marton, A. Hoyt, D.G. Murthy, K.G. Salzman, A.L. et al. Diabetic endothelial dysfunction: The role of poly(ADP-ribose) polymerase activation. Nat. Med. 2001, 7, 108-113.
106. Pacher, P. Liaudet, L. Soriano, F.G. Mabley, J.G. Szabó, E. Szabó, C. The role of poly(ADP-ribose) polymerase in the development of myocardial and endothelial dysfunction in diabetes mellitus. Diabetes 2002, 51, 514-521.
107. Pacher, P. Szabó, C. Role of poly(ADP-ribose) polymerase-1 (PARP) activation in the pathogenesis of diabetic complications: Endothelial dysfunction, as a common underlying theme. Antioxid. Redox Signal. 2005, 7, 1568-1580.
108. Kajstura, J. Fiordaliso, F. Andreoli, A.M. Li, B. Chimenti, S. Medow, M.S. Limana, F. Nadal-Ginard, B. Leri, A. Anversa, P. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 2001, 50, 1414-1424.
109. Szabó, C. Mabley, J.G. Moeller, S.M. Shimanovich, R. Pacher, P. Virag, L. Soriano, F.G. van Duzer, J.H. Williams, W. Salzman, A.L. et al. Pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: Studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol. Med. 2002, 8, 571-580.
110. Mihm, M.J. Coyle, C.M. Schanbacher, B.L. Weinstein, D.M. Bauer, J.A. Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc. Res. 2001, 49, 798-807.
111. Turko, I.V. Marcondes, S. Murad, F. Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am. J. Physiol. Heart Circ. Physiol. 2001, 281, 2289-2294.
112. El-Remessy, A.B. Behzadian, M.A. Abou-Mohamed, G. Franklin, T. Caldwell, R.W. Caldwell, R.B. Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am. J. Pathol. 2003, 162, 1995-2004.
113. El-Remessy, A.B. Abou-Mohamed, G. Caldwell, R.W. Caldwell, R.B. High glucose-induced tyrosine nitration in endothelial cells: Role of eNOS uncoupling and aldose reductase activation. Investig. Ophthalmol. Vis. Sci. 2003, 44, 3135-3143.
114. Onozato, M.L. Tojo, A. Goto, A. Fujita, T. Wilcox, C.S. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB. Kidney Int. 2002, 61, 186-194.
115. Obrosova, I.G. Mabley, J.G. Zsengeller, Z. Charniauskaya, T. Abatan, O.I. Groves, J.T. Szabó, C. Role for nitrosative stress in diabetic neuropathy: Evidence from studies with a peroxynitrite decomposition catalyst. FASEB J. 2005, 19, 401-403.
116. Obrosova, I.G. Drel, V.R. Pacher, P. Ilnytska, O. Wang, Z.Q. Stevens, M.J. Yorek, M.A. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: The relation is revisited. Diabetes 2005, 54, 3435-3441.
117. Johnson, E.L. Glycemic variability in type 2 diabetes mellitus: Oxidative stress and macrovascular complications. Adv. Exp. Med. Biol. 2012, 771, 139-154.
118. Piconi, L. Quagliaro, L. Da Ros, R. Assaloni, R. Giugliano, D. Esposito, K. Szabo, C. Ceriello, A. Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: The role of poly(ADP-ribose) polymerase. J. Thromb. Haemost. 2004, 2, 1453-1459.
119. Durante, W. Sen, A.K. Sunahara, F.A. Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats. Br. J. Pharmacol. 1988, 94, 463-468.
120. Obrosova, I.G. Minchenko, A.G. Marinescu, V. Fathallah, L. Kennedy, A. Stockert, C.M. Frank, R.N. Stevens, M.J. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 2001, 44, 1102-1110.
121. Zhao, H.J. Wang, S. Cheng, H. Zhang, M.Z. Takahashi, T. Fogo, A.B. Breyer, M.D. Harris, R.C. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J. Am. Soc. Nephrol. 2006, 17, 2664-2669.
122. Selvaraju, V. Joshi, M. Suresh, S. Sanchez, J.A. Maulik, N. Maulik, G. Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease-An overview. Toxicol. Mech. Methods 2012, 22, 330-335.
123. Schinzari, F. Tesauro, M. Rovella, V. Galli, A. Mores, N. Porzio, O. Lauro, D. Cardillo, C. Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome. Am. J. Physiol. Endocrinol. Metab. 2010, 299, E947-E952.
124. Schinzari, F. Tesauro, M. Rovella, V. di Daniele, N. Gentileschi, P. Mores, N. Campia, U. Cardillo, C. Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab. 2012, 303, E806-E811.
125. Tesauro, M. Schinzari, F. Adamo, A. Rovella, V. Martini, F. Mores, N. Barini, A. Pitocco, D. Ghirlanda, G. Lauro, D. et al. Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndrome. Diabetes Care 2013, 36, 683-689.
126. Emerging Risk Factors Collaboration; Sarwar, N. Gao, P. Seshasai, S.R. Gobin, R. Kaptoge, S. di angelantonio, E. Ingelsson, E. Lawlor, D.A. Selvin, E. et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375, 2215-2222.
127. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. U.S. Department of Health and Human Services: Atlanta, GA, USA, 2011.
128. Huang, A. Yang, Y.M. Feher, A. Bagi, Z. Kaley, G. Sun, D. Exacerbation of endothelial dysfunction during the progression of diabetes: Role of oxidative stress. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 302, R674-R681.
129. Chung, S.S. Ho, E.C. Lam, K.S. Chung, S.K. Contribution of polyol pathway to diabetes-induced oxidative stress. J. Am. Soc. Nephrol. 2003, 14, S233-S236.
130. Wautier, J.L. Schmidt, A.M. Protein glycation: A firm link to endothelial cell dysfunction. Circ. Res. 2004, 95, 233-238.
131. Candido, R. Forbes, J.M. Thomas, M.C. Thallas, V. Dean, R.G. Burns, W.C. Tikellis, C. Ritchie, R.H. Twigg, S.M. Cooper, M.E. et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ. Res. 2003, 92, 785-792.
132. Stitt, A.W. Li, Y.M. Gardiner, T.A. Bucala, R. Archer, D.B. Vlassar, H. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am. J. Pathol. 1997, 150, 523-531.
133. Nishino, T. Horii, Y. Shiiki, H. Yamamoto, H. Makita, Z. Bucala, R. Dohi, K. Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy. Hum. Pathol. 1995, 26, 308-313.
134. Geraldes, P. King, G.L. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ. Res. 2010, 106, 1319-1331.
135. Inoguchi, T. Battan, R. Handler, E. Sportsman, J.R. Heath, W. King, G.L. Preferential elevation of protein kinase C isoform β II and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation. Proc. Natl. Acad. Sci. USA 1992, 89, 11059-11063.
136. Ganz, M.B. Seftel, A. Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E. Am. J. Physiol. Endocrinol. Metab. 2000, 278, E146-E152.
137. Brownlee, M. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 1995, 46, 223-234.
138. Wallace, D.C. Disease of the mitochondrial DNA. Annu. Rev. Biochem. 1992, 61, 1175-1212.
139. Korshunov, S.S. Skulachev, V.P. Starkov, A.A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997, 416, 15-18.
140. Yu, T. Robotham, J.L. Yoon, Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc. Natl. Acad. Sci. USA 2006, 103, 2653-2658.
141. Ola, M.S. Nawaz, M.I. Khan, H.A. Alhomida, A.S. Neurodegeneration and neuroprotection in diabetic retinopathy. Int. J. Mol. Sci. 2013, 14, 2559-2572.
142. Rodríguez-Carrizalez, A.D. Castellanos-González, J.A. Martínez-Romero, E.C. Miller-Arrevillaga, G. Villa-Hernández, D. Hernández-Godínez, P.P. Ortiz, G.G. Pacheco-Moisés, F.P. Cardona-Muñoz, E.G. Miranda-Díaz, A.G. Oxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathy. J. Diabetes 2013, doi:10.1111/1753-0407.12076.
143. Yamagishi, S. Maeda, S. Matsui, T. Ueda, S. Fukami, K. Okuda, S. Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes. Biochim. Biophys. Acta 2012, 1820, 663-671.
144. Choudhuri, S. Dutta, D. Sen, A. Chowdhury, I.H. Mitra, B. Mondal, L.K. Saha, A. Bhadhuri, G. Bhattacharya, B. Role of N-ε-carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus. Mol. Vis. 2013, 19, 100-113.
145. Yafai, Y. Iandiev, I. Lange, J. Yang, X.M. Wiedemann, P. Bringmann, A. Eichler, W. Basic fibroblast growth factor contributes to a shift in the angioregulatory activity of retinal glial (Müller) cells. PLoS One 2013, 8, e68773.
146. Taniguchi, K. Xia, L. Goldberg, H.J. Lee, K.W. Shah, A. Stavar, L. Masson, E.A.Y. Momen, A. Shikatani, E.A. John, R. et al. Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice. Diabetes 2013, doi:10.2337/db12-1010.
147. Al-Kafaji, G. Golbahar, J. High glucose-induced oxidative stress increases the copy number of mitochondrial DNA in human mesangial cells. Biomed. Res. Int. 2013, 2013, 754946.
148. Van Dam, P.S. Cotter, M.A. Bravenboer, B. Cameron, N.E. Pathogenesis of diabetic neuropathy: Focus on neurovascular mechanisms. Eur. J. Pharmacol. 2013, doi:10.1016/j.ejphar.2013.07.017.
149. Hosseini, A. Abdollahi, M. Diabetic neuropathy and oxidative stress: Therapeutic perspectives. Oxid. Med. Cell. Longev. 2013, 2013, 168039:1-168039:15.
150. Evans, J.L. Maddux, B.A. Goldfine, I.D. The molecular basis for oxidative stress-induced insulin resistance. Antioxid. Redox Signal. 2005, 7, 1040-1052.
151. Jacob, S. Henriksen, E.J. Tritschler, H.J. Augustin, H.J. Dietze, G.J. Improvement of insulin-stimulatedglucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Exp. Clin. Endocrinol. Diabetes 1996, 104, 284-288.
152. Jacob, S. Ruus, P. Hermann, R. Tritschler, H.J. Maerker, E. Renn, W. Augustin, H.J. Dietze, G.J. Rett, K. Oral administration of RAC-α-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: A placebo-controlled pilot trial. Free Radic. Biol. Med. 1999, 27, 309-314.
153. Konrad, T. Vicini, P. Kusterer, K. Hoflich, A. Assadkhani, A. Bohles, H.J. Sewell, A. Tritschler, H.J. Cobelli, C. Usadel, K.H. α-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 1999, 22, 280-287.
154. Fulghesu, A.M. Ciampelli, M. Muzj, G. Belosi, C. Selvaggi, L. Ayala, G.F. Lanzone, A. N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil. Steril. 2002, 77, 1128-1135.
155. Caballero, B. Vitamin E improves the action of insulin. Nutr. Rev. 1993, 51, 339-340.
156. Paolisso, G. D'Amore, A. Galzerano, D. Balbi, V. Giugliano, D. Varricchio, M. D'Onofrio, F. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care 1993, 16, 1433-1437.
157. Paolisso, G. D'Amore, A. Giugliano, D. Ceriello, A. Varricchio, M. D'Onofrio, F. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am. J. Clin. Nutr. 1993, 57, 650-656.
158. Paolisso, G. di Maro, G. Galzerano, D. Cacciapuoti, F. Varricchio, G. Varricchio, M. D'Onofrio, F. Pharmacological doses of vitamin E and insulin action in elderly subjects. Am. J. Clin. Nutr. 1994, 59, 1291-1296.
159. Hirashima, O. Kawano, H. Motoyama, T. Hirai, N. Ohgushi, M. Kugiyama, K. Ogawa, H. Yasue, H. Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: Possible role of reactive oxygen species. J. Am. Coll. Cardiol. 2000, 35, 1860-1866.
160. Chevion, M. Berenshtein, E. Stadtman, E.R. Human studies related to protein oxidation: Protein carbonyl content as a marker of damage. Free Radic. Res. 2000, 33, S99-S108.
161. Czernichow, S. Couthouis, A. Bertrais, S. Vergnaud, A.C. Dauchet, L. Galan, P. Hercberg, S. Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: Association with dietary intake and plasma concentrations. Am. J. Clin. Nutr. 2006, 84, 395-399.
162. Gomez-Perez, F.J. Valles-Sanchez, V.E. Lopez-Alvarenga, J.C. Choza-Romero, R. Ibarra Pascuali, J.J. Gonzalez Orellana, R. Perez Ortiz, O.B. Rodriguez Padilla, E.G. Aguilar Salinas, C.A. Rull, J.A. Vitamin E modifies neither fructosamine nor HbA1c levels in poorly controlled diabetes. Rev. Investig. Clin. 1996, 48, 421-424.
163. Liu, S. Lee, I.M. Song, Y. van Denburgh, M. Cook, N.R. Manson, J.E. Buring, J.E. Vitamin E and risk of type 2 diabetes in the women's health study randomized controlled trial. Diabetes 2006, 55, 2856-2862.
164. Scott, J.A. King, G.L. Oxidative stress and antioxidant treatment in diabetes. Ann. N. Y. Acad. Sci. 2004, 1031, 204-213.
165. American diabetes association. Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care 2007, 30, S48-S65.
166. Bjelakovic, G. Nikolova, D. Gluud, L.L. Simonetti, R.G. Gluud, C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. JAMA 2007, 297, 842-857.
167. Bleys, J. Navas-Acien, A. Guallar, E. Serum selenium and diabetes in US adults. Diabetes Care 2007, 30, 829-834.
168. Miller, E.R., 3rd. Pastor-Barriuso, R. Dalal, D. Riemersma, R.A. Appel, L.J. Guallar, E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 2005, 142, 37-46.
169. Ceriello, A. Hypothesis: The "metabolic memory", the new challenge of diabetes. Diabetes Res. Clin. Pract. 2009, 86, S2-S6.
170. El-Osta, A. Brasacchio, D. Yao, D. Pocai, A. Jones, P.L. Roeder, R.G. Cooper, M.E. Brownlee, M. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 2008, 205, 2409-2417.